MedTrace Logo

Sirolimus-Eluting Stent Versus Standard Stent in Diabetic

NCT00755443 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2008-09-19

No results posted yet for this study

Summary

The purpose of this study was to determine whether Sirolimus stent implantation is effective in reducing neointimal hyperplasia as compared to Bare metal stent in diabetic patients with de novo coronary artery stenosis.

Conditions

Interventions

DEVICE

Drug eluting stent

Drug eluting stent implantation

DEVICE

Bare metal stent

Sponsors & Collaborators

  • Hospital Clínico Universitario de Valladolid

    collaborator OTHER

  • Hospital Universitari de Bellvitge

    collaborator OTHER

  • Hospital de Meixoeiro

    collaborator OTHER_GOV

  • Hospital San Carlos, Madrid

    lead OTHER

Principal Investigators

  • Manel Sabate, Md, PhD · Hospital Clinico San Carlos

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-02-28
Primary Completion
2004-09-30
Completion
2005-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00755443 on ClinicalTrials.gov